Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T12:42:12.320Z Has data issue: false hasContentIssue false
  • English
  • Français

Cholinergic treatment across the spectrum: therapeutic trends in mild to severe dementia

Published online by Cambridge University Press:  01 September 2006

STEPHEN SALLOWAY
STEPHEN SALLOWAY
Affiliation:
Butler Hospital and Brown Medical School, Providence, RI, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The field of Alzheimer's disease (AD) research is in transition. Advances in our knowledge of AD pathology are translating into improved understanding of pharmacological agents that may have benefits across the spectrum of the illness. A major focus of current research is the potential ability of cholinergic therapy to enhance function and quality of life in all patients affected by AD, from the mildest to the most advanced stages.

Type
Guest Editorial
Information
International Psychogeriatrics , Volume 18 , Issue s1 , September 2006 , pp. S1 - S2
Copyright
International Psychogeriatric Association 2006